• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素、甲硝唑和夫西地酸对艰难梭菌的药效学研究。

Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.

作者信息

Odenholt Inga, Walder Mats, Wullt Marlene

机构信息

Infectious Diseases Research Unit, Department of Clinical Sciences, Malmö, Sweden.

出版信息

Chemotherapy. 2007;53(4):267-74. doi: 10.1159/000104471. Epub 2007 Jun 25.

DOI:10.1159/000104471
PMID:17595541
Abstract

BACKGROUND

Pharmacodynamic studies of antibiotics have attracted great interest in recent years. However, studies on the pharmacodynamics of different antibiotics against Clostridium difficile are scarce.

METHODS

The postantibiotic effects (PAE) and the postantibiotic sub-minimum inhibitory concentration (MIC) effects (PA SME) of vancomycin, metronidazole and fusidic acid were investigated by viable counts against three different strains of C. difficile. The killing rate and extent of the three antibiotics against the same strains were also studied by adding 2, 4, 8, 16 and 32x MIC of the three antibiotics, respectively.

RESULTS

Metronidazole exerted a very rapid bactericidal effect at concentrations of 8x MIC and above against all three strains investigated. Vancomycin gave overall less kill in comparison to metronidazole and was bacteriostatic against two of the three strains. Fusidic acid exerted a concentration-dependent killing against two of the strains. Vancomycin exerted short PAEs and PA SMEs against all three strains. Significantly longer PAEs and PA SMEs were noted for fusidic acid. Metronidazole gave similar short PAEs like vancomycin but longer PA SMEs were noted against two of the investigated strains.

CONCLUSION

Metronidazole exerted the most prominent bactericidal effect greater than fusidic acid and greater than vancomycin. Fusidic acid gave overall the longest PAEs and PA SMEs greater than metronidazole and greater than vancomycin.

摘要

背景

近年来,抗生素的药效学研究备受关注。然而,针对艰难梭菌的不同抗生素药效学研究却很匮乏。

方法

通过活菌计数法,研究了万古霉素、甲硝唑和夫西地酸对三株不同艰难梭菌菌株的抗生素后效应(PAE)及抗生素后亚最低抑菌浓度(MIC)效应(PA SME)。同时,分别加入三种抗生素的2、4、8、16和32倍MIC,研究这三种抗生素对同一菌株的杀菌率和杀菌程度。

结果

甲硝唑在8倍MIC及以上浓度时,对所有三株受试菌株均呈现出非常快速的杀菌作用。与甲硝唑相比,万古霉素的总体杀菌效果较差,且对三株菌株中的两株具有抑菌作用。夫西地酸对其中两株菌株呈现浓度依赖性杀菌作用。万古霉素对所有三株菌株的PAE和PA SME均较短。夫西地酸的PAE和PA SME明显更长。甲硝唑的PAE与万古霉素相似,但对两株受试菌株的PA SME更长。

结论

甲硝唑的杀菌作用最为显著,大于夫西地酸且大于万古霉素。夫西地酸的PAE和PA SME总体最长,大于甲硝唑且大于万古霉素。

相似文献

1
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.万古霉素、甲硝唑和夫西地酸对艰难梭菌的药效学研究。
Chemotherapy. 2007;53(4):267-74. doi: 10.1159/000104471. Epub 2007 Jun 25.
2
Antibacterial activity of teicoplanin against Clostridium difficile.替考拉宁对艰难梭菌的抗菌活性。
Southeast Asian J Trop Med Public Health. 1996 Sep;27(3):606-9.
3
Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.替考拉宁、万古霉素和甲硝唑对艰难梭菌的杀菌活性。
Anaerobe. 2010 Jun;16(3):220-2. doi: 10.1016/j.anaerobe.2009.12.002. Epub 2010 Jan 4.
4
[Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].[1998年至2002年间分离出的艰难梭菌菌株对甲硝唑和万古霉素的敏感性评估]
Med Dosw Mikrobiol. 2003;55(3):253-8.
5
Antibiotic resistance of Clostridium difficile isolates.
Cytobios. 1991;65(262-263):149-53.
6
In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.甲硝唑与万古霉素联合使用对艰难梭菌的体外作用
J Antimicrob Chemother. 2009 May;63(5):1076. doi: 10.1093/jac/dkp048. Epub 2009 Feb 24.
7
In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.达托霉素、万古霉素和青霉素对艰难梭菌、产气荚膜梭菌、大芬戈尔德菌和痤疮丙酸杆菌的体外活性。
Antimicrob Agents Chemother. 2006 Aug;50(8):2728-31. doi: 10.1128/AAC.00357-06.
8
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.万古霉素在人体肠道模型中对流行艰难梭菌菌株的活性。
J Antimicrob Chemother. 2009 Mar;63(3):520-5. doi: 10.1093/jac/dkn502. Epub 2008 Dec 26.
9
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].[2001年至2007年在让-韦迪耶-勒内-米雷医院分离出的艰难梭菌菌株的流行病学研究]
Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7.
10
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.基因分型不同的艰难梭菌克隆菌株对奥硝唑的体外敏感性
J Antimicrob Chemother. 2008 Oct;62(4):762-5. doi: 10.1093/jac/dkn276. Epub 2008 Jul 7.

引用本文的文献

1
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.艰难梭菌的万古霉素敏感性降低与初始治愈率和持续临床应答率降低相关。
Clin Infect Dis. 2024 Jul 19;79(1):15-21. doi: 10.1093/cid/ciae087.
2
Antimicrobial Efficacy Evaluations of Metronidazole against Clostridioides difficile Infection using Fecal Pharmacokinetic and Pharmacodynamic Analyses.应用粪便药代动力学和药效学分析评估甲硝唑治疗艰难梭菌感染的抗菌疗效。
Pharm Res. 2023 Jul;40(7):1799-1806. doi: 10.1007/s11095-023-03537-6. Epub 2023 May 24.
3
Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.
抗阿米巴药物二碘羟基喹啉再利用治疗艰难梭菌感染。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.02115-19.
4
Effect of sub-MIC values of metronidazole, ciprofloxacin, and imipenem on the growth and toxin production in .甲硝唑、环丙沙星和亚胺培南低于最低抑菌浓度值对……生长和毒素产生的影响
Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S163-S168.
5
Detection and Investigation of Eagle Effect Resistance to Vancomycin in With an ATP-Bioluminescence Assay.采用ATP生物发光法检测和研究万古霉素的鹰效应耐药性
Front Microbiol. 2018 Jul 2;9:1420. doi: 10.3389/fmicb.2018.01420. eCollection 2018.
6
A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.一项针对甲硝唑和万古霉素治疗艰难梭菌感染的荟萃分析,按疾病严重程度分层。
Braz J Infect Dis. 2015 Jul-Aug;19(4):339-49. doi: 10.1016/j.bjid.2015.03.006. Epub 2015 May 19.
7
In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile.艰难梭菌对SMT19969及对照药物的体外敏感性,以及SMT19969及对照药物对艰难梭菌的杀菌动力学和抗生素后效应。
J Antimicrob Chemother. 2015;70(6):1751-6. doi: 10.1093/jac/dkv006. Epub 2015 Feb 3.
8
Clinical update for the diagnosis and treatment of Clostridium difficile infection.艰难梭菌感染的诊断与治疗临床进展
World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):1-26. doi: 10.4292/wjgpt.v5.i1.1.
9
Postantibiotic effect of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile. fidaxomicin 和其主要代谢产物 OP-1118 对艰难梭菌的抗生素后效应。
Antimicrob Agents Chemother. 2011 Sep;55(9):4427-9. doi: 10.1128/AAC.00104-11. Epub 2011 Jun 27.
10
Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile.法昔洛韦及其主要代谢物 OP-1118 对艰难梭菌的杀菌动力学。
J Med Microbiol. 2011 Aug;60(Pt 8):1213-1217. doi: 10.1099/jmm.0.029470-0. Epub 2011 Feb 24.